Fetoscopic laser ablation vs standard management for Type‐ II and Type‐ III vasa previa
Ultrasound in Obstetrics & Gynecology · 2026
DOI: 10.1002/uog.70186 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Ultrasound in Obstetrics & Gynecology, 2026. Verfasst von S Backley und 11 weiteren Autor:innen. Beteiligte Einrichtung: UTHealth Houston Fetal Institute, Division of Fetal Intervention, Department of Obstetrics, Gynecology and Reproductive Sciences, McGovern Medical Sc…. Hauptthemen laut MEDLINE: Vasa Previa, Laser Therapy, Fetoscopy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The standard management (SM) for vasa previa (VP) includes antepartum inpatient admission at 28–32 weeks' gestation followed by Cesarean delivery at 34–37 weeks. Case reports and case series have reported on fetoscopic laser ablation (FLA) as an alternative management approach for Types‐II and ‐III VP. This study compared maternal and neonatal outcomes in patients with Type‐II or ‐III VP who underwent third‐trimester FLA with those who underwent SM.
Methods
This was a cohort study of all antenatally diagnosed cases of Type‐II or ‐III VP identified by ultrasound at, or referred to, two large referral centers in the USA between September 2016 and December 2023. Patients undergoing elective FLA were prospectively followed in both centers, while patients in the SM cohort were selected retrospectively from a single center. The primary outcome was gestational age at delivery. Comparative analysis was performed between SM and FLA cohorts.
Results
There were 67 singleton pregnancies complicated by Type‐II or ‐III VP, of which 35 (52.2%) underwent FLA. There were no differences in baseline demographics between the two cohorts. The median gestational age at delivery was 36.0 (interquartile range (IQR), 35.0–37.6) weeks in the FLA cohort and 34.4 (IQR, 33.4–35.0) weeks in the SM cohort ( P < 0.001). The rate of vaginal delivery in the FLA cohort was 62.9%. Individuals who underwent FLA had a shorter maternal antepartum stay than did those with SM (median, 1 (IQR, 0–3) days vs 16 (IQR, 7–23) days; P < 0.001). The probability of preterm delivery was higher with SM than with FLA (hazard ratio, 0.24 (95% CI, 0.14–0.44)). The need for neonatal blood transfusion was lower in the FLA cohort than in the SM cohort (0% vs 18.8%; P = 0.009).
Conclusions
Third‐trimester FLA offers an alternative to SM for pregnancies complicated by Type‐II or ‐III VP, as it is associated with delivery at a later gestational age and facilitates the option of vaginal delivery. Further research is needed to assess the efficacy of FLA and to provide adequate power to evaluate the potential benefits for both maternal and neonatal outcomes. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UTHealth Houston Fetal Institute, Division of Fetal Intervention, Department of Obstetrics, Gynecology and Reproductive Sciences, McGovern Medical School at UTHealth Houston, Houston, TX, USA.
- Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
ORCID-Profile: S Backley, E P Bergh, E Hernandez-Andrade, J Espinoza, R Papanna
Zitieren
APA
Backley, S., Chmait, R. H., Bergh, E. P., Agarwal, N., Llanes, A., Hamadeh, G., Hernandez-Andrade, E., Johnson, A., Espinoza, J., Salazar, A., Zhu, S., & Papanna, R. (2026). Fetoscopic laser ablation vs standard management for Type‐ II and Type‐ III vasa previa. Ultrasound in Obstetrics & Gynecology. https://doi.org/10.1002/uog.70186
Vancouver
Backley S, Chmait RH, Bergh EP, Agarwal N, Llanes A, Hamadeh G, et al. Fetoscopic laser ablation vs standard management for Type‐ II and Type‐ III vasa previa. Ultrasound in Obstetrics & Gynecology. 2026. doi:10.1002/uog.70186
BibTeX
@article{Backley2026,
author = {Backley, S and Chmait, R H and Bergh, E P and Agarwal, N and Llanes, A and Hamadeh, G and Hernandez-Andrade, E and Johnson, A and Espinoza, J and Salazar, A and Zhu, S and Papanna, R},
title = {Fetoscopic laser ablation vs standard management for Type‐ II and Type‐ III vasa previa},
journal = {Ultrasound in Obstetrics & Gynecology},
year = {2026},
doi = {10.1002/uog.70186}
}
EUVIMED